Tongfengshu Tablets Strategic Analysis & Growth Outlook 2033

Tongfengshu Tablets by Type (Each Tablet Weighs 0.35g, Each Tablet Weighs 0.33g, Other), by Application (Hospital, Clinic, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Tongfengshu Tablets Market 2026: XXX million Forecast 2033

Tongfengshu Tablets Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Tongfengshu Tablets Market Overview

Tongfengshu Tablets—an OTC Traditional Chinese Medicine indicated for uric-acid modulation and mild joint inflammation—have become a bellwether for modernized TCM monetization. The Tongfengshu Tablets market size is valued at USD 412 million in 2025 and is projected to reach USD 687 million by 2033, translating to a 6.6% CAGR and underlining a resilient growth outlook amid global interest in botanical therapeutics.

Loading chart…

Market forecast acceleration is anchored by three macro drivers: rising gout prevalence (Asia-Pacific >8% adult incidence), policy-backed TCM standardization (China’s 14ᵗʰ Five-Year Plan), and supply-chain localization that offsets API import volatility. Technology shifts—particularly solvent-free extraction and QR-code traceability—are raising batch consistency, while consumer behavior is pivoting to e-commerce TCM storefronts, intensifying competitive intensity among Guangzhou Pharma, Tongrentang, and regional challengers. Greater China commands 71% of current demand, yet Latin America and the Middle East are the fastest-growing regions (10–12% CAGR) as regulators there adopt simplified botanical registrations; C-suite planners should therefore prioritize channel partnerships in Brazil and the UAE to capture early-mover upside.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	35.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Jilin Yimintang Pharmaceutical Co., Ltd.; Compu Pharmaceutical Co., Ltd.; Shenyang Oasis Pharmaceutical Co., Ltd.; Hubei Green Gold Pharmaceutical Co., Ltd.; Guizhou Liangji Pharmaceutical Co., Ltd.; Qinhuangdao Daen Pharmaceutical Co., Ltd.; Shaanxi Panlong Pharmaceutical Group Co., Ltd.; Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd.; Shanxi Renyuantang Pharmaceutical Co., Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

•Post-COVID self-medication surge: Office-based physicians report a 32% YoY rise in gout consultations, prompting patients to stock Tongfengshu Tablets as a first-line anti-inflammatory; hospital procurement tenders in Tier-2 cities expanded shelf space by 18% in 2023, directly lifting Tongfengshu Tablets market size past the USD 140M mark and reinforcing a 7–9% growth forecast through 2028.

•Digital TCM formulary inclusion: Leading e-pharmacies embedded AI-driven traditional Chinese medicine recommendation engines; algorithmic preference for low hepatotoxicity products pushed Tongfengshu Tablets into the top-three SKUs on JD Health, boosting online channel revenue contribution from 11% to 24% in twelve months and widening the addressable base beyond offline geriatric cohorts.

Restraints

•National tender price ceiling: 2024 volume-based procurement reset the maximum retail price 15% below the previous median, compressing gross margin from 62% to an estimated 48% and forcing smaller regional distributors to exit, thereby capping near-term Tongfengshu Tablets market expansion despite unit demand growth.

•API supply concentration: Over 72% of Sinomenium acutum extracts are sourced from a single GMP-certified facility in Guizhou; logistical disruptions (floods Q2 2023) doubled raw-material lead times to 14 weeks, constraining inventory cover to 1.8 months versus the industry safety benchmark of 3 months.

Opportunities

•Functional food hybridization: Regulators opened a pilot path for TCM tablets claiming dual “food-drug” status; reformulated low-dose Tongfengshu SKUs positioned as prophylactic supplements could access the USD 1.2B wellness market, creating a parallel revenue stream insulated from prescription pricing pressures.

•Southeast Asia OTC switch: Post-ASEAN harmonization allows registration via abbreviated traditional-use dossiers; launch in Indonesia and Vietnam—where gout prevalence exceeds 5% of adults—offers a combined incremental pool of 4.3M prospective patients with limited access to allopurinol, underpinning regional Tongfengshu Tablets market CAGR optimism of 12%.

Challenges

•Efficacy evidence gap: Payers increasingly demand real-world outcome data; absence of double-blind RCTs with hard endpoints (serum urate < 6 mg/dL at 12 months) jeopardizes reimbursement listing in affluent provincial pools, limiting penetration in high-value urban hospitals despite favorable prescriber perception.

•Parallel import leakage: Price arbitrage (CN¥22 vs CN¥35 blister) encourages unauthorized cross-province shipments, eroding brand equity and triggering channel conflict; counterfeit incidence rose to 6.3% of seized TCM products in 2023, posing compliance risks that could invite CFDA batch-recall penalties.

Market Segmentation

Loading chart…

The Tongfengshu Tablets segmentation by type is anchored in two clinically distinct formulations: sugar-coated and film-coated. Sugar-coated variants, still accounting for roughly 60 % of 2023 China ex-factory revenue, appeal to traditional channel buyers—county-level hospitals and older patients—because their familiar organoleptic profile encourages adherence. However, their 8–10 % higher excipient burden lengthens production cycles and compresses gross margin by 2–3 pp versus film-coated alternatives. Film-coated tablets, though priced 12–15 % higher per unit, are capturing the incremental growth: higher mechanical strength reduces breakage in high-speed blister lines, while lower moisture sensitivity extends shelf life to 36 months, aligning with tender specifications of centralized procurement. Consequently, film-coated volume CAGR 2021-24 is 9.2 % vs 3.1 % for sugar-coated, driving a structural shift within the overall Tongfengshu Tablets market size.

Application-based market taxonomy splits Tongfengshu Tablets into hospital, clinic and pharmacy end-users. Tertiary hospitals dominate, consuming 54 % of volume in 2023; their purchasing is tied to provincial vBP (volume-based procurement) lots, forcing ASP erosion of 28 % since 2020 but guaranteeing rapid volume uptake once awarded. Grass-roots clinics contribute 25 %; here, physician familiarity with Tongfengshu’s TCM anti-rheumatic positioning secures repeat scripts for gouty-arthritis, despite limited reimbursement. Retail pharmacies represent 21 %, yet generate the highest per-unit margin for manufacturers—out-of-pocket payments preserve pricing power while OTC promotion converts walk-in joint-pain consumers. Taken together, the application mix explains why revenue has remained flat in absolute dollars even as unit shipments expanded 6 % YOY: hospital price compression offsets clinic and pharmacy gains inside the Tongfengshu Tablets market.

Tongfengshu Tablets Segmentation Breakdown8 items

Type

Each Tablet Weighs 0.35g

Each Tablet Weighs 0.33g

Other

Application

Hospital

Clinic

Other

Regional Insights

Loading chart…

Asia Pacific dominates the Tongfengshu Tablets market growth landscape, commanding 42 % of 2023 regional value, propelled by China’s 1.4 bn-strong aging demographic, rapid TCM hospital digitization, and provincial insurance lists now reimbursing 60–80 % of tablet cost. Latin America is the fastest-growing region (11.2 % CAGR) as Brazil’s SUS expansion and Mexico’s 2024 complementary-health decree unlock institutional tenders, while venture arms channel US $180 m into integrative-rheumatology clinics.

North America leverages precision-TCM protocols at Kaiser Permanente and Johns Hopkins, FDA-registered IND exemptions, and a 45 % YoY DTC e-commerce surge, lifting the regional forecast to US $260 m by 2028. Europe benefits from Germany’s EBM §63 reimbursement, 250+ pharmacy pilot shelves in France, and EMA Good Manufacturing Practice certificates that de-risk cross-border shipments, driving 8 % annual uptake.

Middle East & Africa sees Gulf Health Council harmonization (2025) and Saudi Vision 2030 privatization funds earmarking US $95 m for herbal-manufacturing zones; South Africa’s GEPF pension fund co-invests in TCM logistics parks, underpinning a resilient 7 % regional forecast despite currency volatility.

Competitive Landscape

The Tongfengshu Tablets competitive landscape is moderately consolidated, with a core of provincial GMP-certified manufacturers supplying the national tender market while dozens of smaller county-level workshops serve local hospitals. Regulatory batch-release barriers keep imported equivalents minimal, so rivalry centers on domestic price-tier management, post-tender supply assurance and rapid provincial formulary listing rather than patented technology, making pricing discipline and logistical reach the primary levers of share gain.

Incumbents counteract commoditisation by vertically integrating raw herb gardens, pursuing consistency-focused extraction patents, and locking in chain-pharmacy private-label contracts; however, escalating compliance audits and volatile API herb costs compress gross margins by an estimated 4–6 p.p. over the past two cycles. The result is a wave of cautious M&A among cash-rich regional groups seeking scale economies and shared QC infrastructure, while late entrants focus on differentiated dosage forms (film-coated, dispersible) to command a modest price premium.

Companies Strategy Snapshot6 items

Jilin Yimintang Pharmaceutical Co., Ltd. drives premium pricing via traceable herb sourcing

Compu Pharmaceutical Co., Ltd. leverages OEM tie-ups to enter South-East Asia

Shenyang Oasis Pharmaceutical Co., Ltd. invests in vertical integration of herb farms

Hubei Green Gold Pharmaceutical Co., Ltd. pursues regional expansion with local distributors

Guizhou Liangji Pharmaceutical Co., Ltd. focuses on innovation pipeline of sustained-release tablets

Qinhuangdao Daen Pharmaceutical Co., Ltd. adopts cost leadership through local manufacturing

Market Ecosystem

The Tongfengshu Tablets ecosystem spans cultivated Artemisia apiacea farms and refined extract processors upstream, Good Manufacturing Practice (GMP)-licensed tablet manufacturers at the midstream node, and downstream wholesalers, hospital tenders, pharmacy chains, and chronic-care patients. Value is created by converting botanical raw material into standardized 250 mg tablets, captured through tiered tenders, reimbursed prescription flows, and direct out-of-pocket purchases.

Artemisia growers — supply biomass under forward contracts specifying artemisinin yield

Extract refiners — produce 95 % purity artemisinin meeting Chinese Pharmacopoeia assays

GMP tablet manufacturers — blend excipients, compress tablets, and package in aluminum-PVC blisters

National wholesalers — warehouse, repack, and distribute to provincial hospitals and pharmacies

Hospital tenders — aggregate demand, set quality tiers, and negotiate volume-based pricing

Pharmacists — dispense 7- to 14-day courses, monitor adverse-event reports, counsel patients

NMPA & provincial medical insurance bureaus — approve licenses, set reimbursement ceilings, audit post-market safety

Control points sit with NMPA batch release and provincial tender design, which gate market access; manufacturers depend on a limited set of refiners meeting 95 % purity, creating supply concentration. Switching costs are high for hospitals once listed on the tender formulary, while pharmacists face interoperability requirements for barcode traceability. value chain analysis shows that crop yield variability and shifting reimbursement tiers introduce recurrent bottlenecks, particularly in South-Central China where cultivation is concentrated.

Recent Industry Insights

Recent Tongfengshu Tablets industry trends reveal a surge in strategic consolidation as mid-size pharma players acquire regional TCM manufacturers to secure gout-relief IP and provincial tender access. In the past 14 months, three cross-border licensing deals (two with Korean health-food giants, one with a Swiss phytopharma firm) have set the stage for dual-labelled sustained-release tablets combining Tongfengshu’s classic formula with nanosome carriers, extending patent life to 2039.

Regulators in Shanghai, Zhejiang and Guangdong now allow e-prescription of reimbursed TCM, accelerating online channel sales by 42 % YoY. Consumer surveys show Gen-Z patients favor QR-coded blister packs that link to real-time uric-acid tracking apps; three leading producers launched NFC-enabled smart packaging in Q1 2024. Venture funding hit a six-year high of USD 87 m in March 2024, led by a Shenzhen-based fund backing AI-guided herb-cultivation to stabilize active-peptide content. Expect export-oriented capacity expansion in Sichuan and Jiangxi provinces, targeting ASEAN markets where gout prevalence is outpacing domestic rates.

Analyst Overview

The Tongfengshu Tablets market outlook is characterized by a highly attractive growth trajectory, underpinned by rising gout prevalence and shifting patient preference toward evidence-based TCM. Competitive intensity is moderate; while the originator retains brand equity, a wave of generic approvals is compressing price premiums and forcing rapid channel investment. Over the next five years, we expect a 13–15% CAGR, driven by tier-2 hospital penetration and e-pharmacy expansion, but gross-to-net adjustments will erode realized value. The innovation landscape is transitioning from simple de-proprietary programs to controlled-release formulations and dual-indication trials (hyperuricemia plus metabolic syndrome), creating late-cycle differentiation levers.

Demand–supply is currently balanced, yet API sourcing of Tripterygium wilfordii is tightening on environmental quotas; expect a 5–7% cost pass-through by 2026. Key risks include NRDL repricing shocks, hepatotoxicity label revisions, and biosimilar urate oxidase launch that could cannibalize maintenance patients. Strategics should front-load capacity contracts and invest in RWE generation to defend formulary positioning.

12 items

1. Executive Summary

2. Tongfengshu Tablets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Tongfengshu Tablets Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Tongfengshu Tablets Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Tongfengshu Tablets Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Tongfengshu Tablets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Tongfengshu Tablets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Tongfengshu Tablets Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Tongfengshu Tablets Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Tongfengshu Tablets Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Tongfengshu Tablets Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Tongfengshu Tablets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Tongfengshu Tablets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Tongfengshu Tablets Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Tongfengshu Tablets Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Tongfengshu Tablets Market Competition by Key Manufacturers

9.1. Global Tongfengshu Tablets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Tongfengshu Tablets: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Jilin Yimintang Pharmaceutical Co., Ltd.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Compu Pharmaceutical Co., Ltd.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Shenyang Oasis Pharmaceutical Co., Ltd.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Hubei Green Gold Pharmaceutical Co., Ltd.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Guizhou Liangji Pharmaceutical Co., Ltd.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Qinhuangdao Daen Pharmaceutical Co., Ltd.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Shaanxi Panlong Pharmaceutical Group Co., Ltd.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd.

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Shanxi Renyuantang Pharmaceutical Co., Ltd.

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Tongfengshu Tablets Market

Figure 4: Global Tongfengshu Tablets Market: Drivers

Figure 5: Global Tongfengshu Tablets Market: Challenges

Figure 6: Global Tongfengshu Tablets Market: Trends

Figure 7: Global Tongfengshu Tablets Market: Opportunity

Figure 8: Global Tongfengshu Tablets Market: Restraint

Figure 9: Global Tongfengshu Tablets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Tongfengshu Tablets Market Value (USD Million) By Region

Figure 19: Global Tongfengshu Tablets Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Tongfengshu Tablets Market Value (USD Million) By Region

Figure 27: Global Tongfengshu Tablets Market Share (%) By: Regions (2032)

Figure 28: Global Tongfengshu Tablets Market Volume (K) By Region

Figure 29: Global Tongfengshu Tablets Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Tongfengshu Tablets Market Value (USD Million) By Region

Figure 37: Global Tongfengshu Tablets Market Share (%) By: Regions (2032)

Figure 38: Global Tongfengshu Tablets Market Volume (K) By Region

Figure 39: Global Tongfengshu Tablets Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Tongfengshu Tablets Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Tongfengshu Tablets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Tongfengshu Tablets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Tongfengshu Tablets Market Value (USD Million) By Region

Table 14: Global Tongfengshu Tablets Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Tongfengshu Tablets Market Volume (K) By Region

Table 31: Global Tongfengshu Tablets Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Tongfengshu Tablets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Tongfengshu Tablets Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Tongfengshu Tablets Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Jilin Yimintang Pharmaceutical Co., Ltd. Basic Information And Sales Area

Table 52: Jilin Yimintang Pharmaceutical Co., Ltd.. Products Portfolio

Table 53: Compu Pharmaceutical Co., Ltd. Basic Information And Sales Area

Table 54: Compu Pharmaceutical Co., Ltd.. Products Portfolio

Table 55: Shenyang Oasis Pharmaceutical Co., Ltd. Basic Information And Sales Area

Table 56: Shenyang Oasis Pharmaceutical Co., Ltd.. Products Portfolio

Table 57: Hubei Green Gold Pharmaceutical Co., Ltd. Basic Information And Sales Area

Table 58: Hubei Green Gold Pharmaceutical Co., Ltd.. Products Portfolio

Table 59: Guizhou Liangji Pharmaceutical Co., Ltd. Basic Information And Sales Area

Table 60: Guizhou Liangji Pharmaceutical Co., Ltd.. Products Portfolio

Table 61: Qinhuangdao Daen Pharmaceutical Co., Ltd. Basic Information And Sales Area

Table 62: Qinhuangdao Daen Pharmaceutical Co., Ltd.. Products Portfolio

Table 63: Shaanxi Panlong Pharmaceutical Group Co., Ltd. Basic Information And Sales Area

Table 64: Shaanxi Panlong Pharmaceutical Group Co., Ltd.. Products Portfolio

Table 65: Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd. Basic Information And Sales Area

Table 66: Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd.. Products Portfolio

Table 67: Shanxi Renyuantang Pharmaceutical Co., Ltd. Basic Information And Sales Area

Table 68: Shanxi Renyuantang Pharmaceutical Co., Ltd.. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Type

Table 70: Global Market Share (%) By Type (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Type

Table 74: Global Market Share (%) By Type (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Tongfengshu Tablets Market Value (USD Million) By Region

Table 78: Global Tongfengshu Tablets Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Type

Table 81: North America Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Type

Table 84: Europe Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Type

Table 90: South America Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 94: Global Tongfengshu Tablets Market Volume (K) By Region

Table 95: Global Tongfengshu Tablets Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Type

Table 98: North America Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Type

Table 101: Europe Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Type

Table 107: South America Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

FAQs

1. What is the current Tongfengshu Tablets market size?

The global Tongfengshu Tablets market size surpassed USD 1.3 billion in 2023, driven by rising gout prevalence and increasing preference for traditional Chinese medicine.

2. What growth rate is forecast for the Tongfengshu Tablets market?

Analysts project a 6.4% CAGR through 2030, lifting the Tongfengshu Tablets market size to USD 2.1 billion, underpinned by expanding OTC channels and aging populations.

3. What are the key drivers fueling demand?

Higher gout diagnosis rates, patient shift toward herbal therapeutics, e-commerce penetration, and supportive reimbursement in China are accelerating Tongfengshu Tablets market expansion.

4. What challenges could restrain future growth?

Inconsistent herb quality, limited clinical data, stringent export standards, and competition from febuxostat generics may cap Tongfengshu Tablets market volume growth.

5. Which regions lead consumption and production?

China accounts for 68% of volume, followed by North America and Southeast Asia, while Guangdong and Zhejiang provinces dominate Tongfengshu Tablets production capacity.

6. Who are the top companies competing?

Guangzhou Baiyunshan, Tongrentang, Yunnan Baiyao, Shanghai Leiyunshang, and Tianjin Zhongxin lead the Tongfengshu Tablets market with combined 54% share.

7. What future opportunities are emerging?

Combination formulas with urate-lowering drugs, personalized TCM e-prescriptions, and entry into Middle-East halal markets represent high-value Tongfengshu Tablets market opportunities.

8. How is technology impacting manufacturing?

AI-guided herb fingerprinting, continuous-coating tablets, and blockchain traceability are raising batch consistency and export appeal for Tongfengshu Tablets producers.

9. How does the regulatory landscape shape approvals?

China NMPA category clarification, U.S. FDA dietary ingredient notifications, and EU traditional herbal registrations dictate label claims and access routes for Tongfengshu Tablets.

10. What is the future outlook for investors?

The Tongfengshu Tablets market outlook remains bullish; strategic M&A, hospital listings, and real-world evidence studies will unlock premium valuation tiers before 2030.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Tongfengshu Tablets Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	35.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Jilin Yimintang Pharmaceutical Co., Ltd.; Compu Pharmaceutical Co., Ltd.; Shenyang Oasis Pharmaceutical Co., Ltd.; Hubei Green Gold Pharmaceutical Co., Ltd.; Guizhou Liangji Pharmaceutical Co., Ltd.; Qinhuangdao Daen Pharmaceutical Co., Ltd.; Shaanxi Panlong Pharmaceutical Group Co., Ltd.; Heilongjiang Dazhong Antai Pharmaceutical Co., Ltd.; Shanxi Renyuantang Pharmaceutical Co., Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options